![Martin Ostrowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Ostrowski
Hoofd Techniek/Wetenschap/O&O bij Ryne Biotechnology, Inc.
Actieve functies van Martin Ostrowski
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Saisei Ventures LLC
![]() Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01-01-2023 | - |
Ryne Biotechnology, Inc.
![]() Ryne Biotechnology, Inc. BiotechnologyHealth Technology Ryne Biotechnology, Inc. is an American US-based biotechnology company that focuses on developing next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology to advance its off-the-shelf neuron replacement therapeutics. Ryne Bio is dedicated to advancing a pipeline targeting neurological diseases by focusing on an iPSC technology platform and forging partnerships with leaders in surgical delivery and clinical development. | Hoofd Techniek/Wetenschap/O&O | 01-03-2022 | - |
Loopbaan van Martin Ostrowski
Eerdere bekende functies van Martin Ostrowski
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Dianomi Therapeutics, Inc.
![]() Dianomi Therapeutics, Inc. BiotechnologyHealth Technology Dianomi Therapeutics, Inc. engages in the development of Mineral Coated Microparticle (MCM) technology. It focuses on the improvement of drug molecules for targeting autoimmune diseases. The company was founded by Barry Kurokawa, William Murphy, Martin Ostrowski, and Anna Clements in 2017 and is headquartered in Madison, WI. | Operationeel Directeur | 01-02-2019 | 31-07-2022 |
Oprichter | 01-02-2019 | 31-07-2020 | |
President | 01-08-2020 | 31-07-2022 | |
Vascugen, Inc.
![]() Vascugen, Inc. BiotechnologyHealth Technology Vascugen, Inc. provides biotechnology services. The company is headquartered in Madison, WI. | Hoofd Techniek/Wetenschap/O&O | 01-06-2017 | 30-11-2019 |
Oprichter | 01-06-2017 | 30-11-2019 | |
mRNA RiboTherapeutics, Inc.
![]() mRNA RiboTherapeutics, Inc. BiotechnologyHealth Technology mRNA RiboTherapeutics, Inc. provides products and technology for making and using ribonucleic acid for translation in cells for clinical research and therapeutics. It offers products for MRNA production in vitro transcription, post-transcriptional capping, co--transcriptional capping, post-transcriptional tailing, modified NTP in vitro transcription, mRNA decapping, and RNase inhibition. The company is headquartered in Madison, WI. | Directeur/Bestuurslid | 01-01-2011 | 02-01-2019 |
Opleiding van Martin Ostrowski
Case Western Reserve University School of Medicine | Graduate Degree |
Case Western Reserve University School of Law | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Operationeel
Founder | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Graduate Degree | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Dianomi Therapeutics, Inc.
![]() Dianomi Therapeutics, Inc. BiotechnologyHealth Technology Dianomi Therapeutics, Inc. engages in the development of Mineral Coated Microparticle (MCM) technology. It focuses on the improvement of drug molecules for targeting autoimmune diseases. The company was founded by Barry Kurokawa, William Murphy, Martin Ostrowski, and Anna Clements in 2017 and is headquartered in Madison, WI. | Health Technology |
Saisei Ventures LLC
![]() Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Ryne Biotechnology, Inc.
![]() Ryne Biotechnology, Inc. BiotechnologyHealth Technology Ryne Biotechnology, Inc. is an American US-based biotechnology company that focuses on developing next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology to advance its off-the-shelf neuron replacement therapeutics. Ryne Bio is dedicated to advancing a pipeline targeting neurological diseases by focusing on an iPSC technology platform and forging partnerships with leaders in surgical delivery and clinical development. | Health Technology |
Vascugen, Inc.
![]() Vascugen, Inc. BiotechnologyHealth Technology Vascugen, Inc. provides biotechnology services. The company is headquartered in Madison, WI. | Health Technology |
mRNA RiboTherapeutics, Inc.
![]() mRNA RiboTherapeutics, Inc. BiotechnologyHealth Technology mRNA RiboTherapeutics, Inc. provides products and technology for making and using ribonucleic acid for translation in cells for clinical research and therapeutics. It offers products for MRNA production in vitro transcription, post-transcriptional capping, co--transcriptional capping, post-transcriptional tailing, modified NTP in vitro transcription, mRNA decapping, and RNase inhibition. The company is headquartered in Madison, WI. | Health Technology |
- Beurs
- Insiders
- Martin Ostrowski
- Ervaring